EPB41L3 and cancer: A loss of EPB41L3, presumably caused by aberrant DNA methylation and/or LOH, is frequently observed in cancer, and EPB41L3 is believed to act as a putative tumor suppressor in some cancers, primarily in NSCLC [9, 35].